This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33387776
rdf:type
wikibase:Item
schema:description
artikull shkencor artykuł naukowy wissenschaftlicher Artikel 2010 թվականի հունվարին հրատարակված գիտական հոդված 2010年論文 سائنسی مضمون 2010年论文 naučni članak artigo científico scienca artikolo artigo científico (publicado na 2010) 2010年の論文 2010年论文 บทความทางวิทยาศาสตร์ tudományos cikk 2010年論文 teaduslik artikkel научни чланак 2010年论文 სამეცნიერო სტატია vetenskaplig artikel мақолаи илмӣ ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article artículu científicu espublizáu en 2010 مقالهٔ علمی vedecký článok videnskabelig artikel (udgivet 2010) επιστημονικό άρθρο 2010 nî lūn-bûn مقالة علمية 2010年论文 научная статья 2010年论文 vitskapeleg artikkel artikulong pang-agham articolo scientifico 2010 թուականի Յունուարին հրատարակուած գիտական յօդուած bài báo khoa học mokslinis straipsnis научни чланак wetenschappelijk artikel 2010年論文 2010년 논문 мақолаи илмӣ наукова стаття, опублікована в січні 2010 vědecký článek article científic article scientific מאמר מדעי artigo científico (publicado na 2010) vitenskapelig artikkel artículo científico publicado en 2010 tieteellinen artikkeli bilimsel makale научна статия article scientifique (publié 2010) 2010年論文 2010年論文 articol științific 2010年论文
p:P577
wds:Q33387776-7558755B-9E0D-43C3-BB74-B00441BC4F08
wdt:P577
2010-01-05T00:00:00Z
p:P2093
wds:Q33387776-D75D8B6F-FE4A-4F02-8775-F69FD2D3349E wds:Q33387776-F1104868-B7C0-4B38-97A4-F1E00912133F wds:Q33387776-D560B549-4915-41CE-9F47-52AA0A0C8EC8 wds:Q33387776-D575D5F8-E827-40AD-AF56-96D48717A083 wds:Q33387776-F27AF046-FB72-48E1-852C-17FA17E3FD1A wds:Q33387776-1FC37201-1C8E-42B3-9B92-13072040C50A wds:Q33387776-39AED11D-F1EB-4B8C-A2E8-3C68FF817022 wds:Q33387776-BD20AFDD-19D8-4A7B-8B7A-01BA6AC2BCBA wds:Q33387776-C3C30E99-287F-4700-A44B-94A6A7BD2160
wdt:P2093
Hitoshi Suzushima Keisuke Shibata Junji Suzumiya Kazuo Tamura Yasushi Takamatsu Junichi Tsukada Hitoshi Matsuoka Kyushu Hematology Organization for Treatment Study Group (K-HOT) Koichi Maeda
rdfs:label
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study
skos:prefLabel
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study
schema:name
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study
p:P50
wds:Q33387776-8EC0D885-2EFC-4BA9-AFFD-394D33A04AEF
wdt:P50
wd:Q98841128
p:P1476
wds:Q33387776-4DFCBCCB-8B43-49E2-A43C-00D451FEFB43
wdt:P1476
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study
p:P304
wds:Q33387776-043B77F2-A31F-4CB0-9A56-850B2DB89FBE
wdt:P304
391-397
p:P31
wds:Q33387776-A395DEF8-F8A2-453A-9BA7-709A2EFF493A
wdt:P31
wd:Q13442814
p:P921
wds:Q33387776-D3308AA1-52FA-43A1-B903-A5478700CCD2 wds:Q33387776-6054D1BD-DF88-41E2-B1F7-F8C1D9012732
wdt:P921
wd:Q379054 wd:Q7168693
p:P698
wds:Q33387776-7F6DA986-C59F-4563-B93A-B8579CFEC7AB
wdtn:P698
n11:20059527
wdt:P698
20059527
p:P1433
wds:Q33387776-18F9E0EF-7F03-4931-94EA-984493B548B6
wdt:P1433
wd:Q15765799
p:P433
wds:Q33387776-8F2466FE-F24E-417A-85B1-1DE8F0000B95
p:P478
wds:Q33387776-C81B444F-F761-43C7-8351-455ED463270E
wdt:P433
5
wdt:P478
84
p:P356
wds:Q33387776-2CBC5039-C2C6-4501-81EE-10CFE78FA715
wdtn:P356
n12:J.1600-0609.2010.01411.X
wdt:P356
10.1111/J.1600-0609.2010.01411.X